Ratings Moves: ING,...
Health Care: Drugs
Redhill Biopharma Ltd (RDHL: NASDAQ)
$10.70 -0.79 | -6.88%
05/24/13 - 03:59 PM ET
Latest Dividend:0.00
Latest Dividend Yield:0.00%
Dividend Ex-Date:12/31/69
Price Earnings Ratio:n/a
Price Earnings Comparisons:
| RDHL | Sector Avg. | S&P 500 |
|---|---|---|
| n/a | 0.00 | 17.70 |
Price Performance History (% change):
| 3 Mo | 1 Yr | 3 Yr |
|---|---|---|
| 0.35 | 0.00 | 0.00 |
| GROWTH | 12 Mo | 3 Yr | CAGR |
|---|---|---|---|
| Revenue | 0.00 | 0.00 | |
| Net Income | 0.00 | 0.00 | |
| EPS | 0.00 | 0.00 |
Earnings for RDHL:
| EBITDA | 0.00 |
| REVENUE | 0.00 |
Average Earnings Estimates
| Qtr (06/13) | Qtr (09/13) | FY (12/13) | FY (12/14) | |
|---|---|---|---|---|
| Average Estimate | $-0.44 | $-0.75 | $-2.15 | $-2.00 |
| Number of Analysts | 1 | 1 | 1 | 1 |
| High Estimate | $-0.44 | $-0.75 | $-2.15 | $-2.00 |
| Low Estimate | $-0.44 | $-0.75 | $-2.15 | $-2.00 |
| Prior Year | $n.a. | $n.a. | $-0.20 | $-2.15 |
| Growth Rate (Year over Year) | n.a.% | n.a.% | -975.00% | 6.98% |
Portfolios with RDHL
- Portfolio NameUser Type
Latest RDHL Headlines from TheStreet
- RedHill Biopharma Reports Financial Results For The First Quarter Of 2013 05.02.13 | 11:05 am
- RedHill Biopharma Submits New Drug Application To U.S. FDA For RHB-103 Anti-Migraine Oral Thin Film 03.27.13 | 06:03 am
- RedHill Biopharma Receives Positive Feedback From A Scientific Advice Meeting In Europe Regarding RHB-101 (Hypertension) Marketing Application Plan 03.19.13 | 05:03 am
- RedHill Biopharma To Present At The 25th Annual ROTH Conference 03.06.13 | 09:03 am
- RedHill Biopharma Provides Update On Development Progress And Planned NDA Submission For RHB-102 (Oncology Support Anti-Emetic) 02.25.13 | 08:02 am
- RedHill Biopharma Reports 2012 Fourth Quarter And Year-End Results 02.19.13 | 11:02 am
- RedHill Biopharma Announces Notice Of Allowance From The United States Patent And Trademark Office For Its Cardio Drug RHB-101 02.19.13 | 09:02 am
- RedHill Biopharma Announces Date Of 2012 Financial Results And Corporate Update Conference Call 02.14.13 | 09:02 am
Press Releases for RDHL
- Bioassociate Announces Valuation Report On RedHill Biopharma, Ltd. - PR Newswire 04.03.13 | 09:04 am
Partner Headlines for RDHL
